INVESTIGATION OF CYTOSTATIC ACTIVITY OF THE METHENAMINE SILVER IN VITRO AND IN VIVO
Background: Developing of novel pharmaceutic agents is an actual topic for chemotherapy. Heavy metals possess a significant cytotoxic properties and some of them are widly introduced in medical practice, e.g. cisplatin.
Aim and Objective of this study was to investigate the cytostatic effects of prospective silver-based preparation on viral bovine leukemia model in vivo and lymphoblast cells in vitro.
Material and Methods: Silver salt of methenamine was suggested as prospective substance and tested was tested on black-motley cattle with bovine leukemia to reveal influence on hematological parameters. Preparation was applied in form of 0.5% solution in different doses and was administered as single intravenous injection. Blood parameters were determined by triple hematological monitoring. Investigation of cytostatic activity was conducted on the leukemic cells of HUT-102 line in Vitro in concentration range of 0.03-3.0 mg/ml.
Results: The results showed normalization of blood parameters in dose-dependent manner after intravenous injection of methenamine silver salt. It was revealed a pronounced inhibitory effect of silver-based drug on the leukemic cells both in vitro and in vivo. Control blood test one month after experimental therapy confirmed the stability of the achieved results.
Conclusion: The tested drug showed a moderate cytostatic effect. Methenamine silver nitrate can be considered as prospective pharmacological agent. Bovine leukemia was shown as a convenient model for the development of new treatment of blood diseases. Continuation of the work is of interest for both veterinary and medical pharmacotherapy.
Keywords: methenamine silver nitrate, HUT 102 cells; lymphocytes, leucosis, cytostatic activity, bovine leukemia, silver hexamethylenetetramine.
2. Meier Stephenson V, Riemer J, Narendran A. The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia. Onco Target Ther 2017;10:2581-93.
3. Kanagaraj B, Prakash A, Wadhwa G. An insight to virtual ligand screening methods for structure-based drug design and methods to predict protein structure and function in lung cancer: approaches and progress. J Crit Rev 2014;1:10-24.
4. Bonde S, Nair S. Advances in liposomal drug delivery system: fascinating types and potential applications. Int J Appl Pharm 2017;9:1-7.
5. Plotnikov E, Silnikov V, Gapeyev A, Plotnikov V. Investigation of DNA-damage and chromosomal aberrations in blood cells under the influence of new silver-based antiviral complex. Adv Pharm Bull 2016;6:71-4.
6. Silnikov V, Plotnikov E, Plotnikov V. Pharmacokinetic studies of new silver-based complex. Int J Pharm Pharm Sci 2015;7:41-3.
7. Mangaiyarkkarasi P, Arulantony S. DNA cleavage, cytotoxic activities, and antimicrobial studies of some novel schiff base transition metal complexes derived from 4-aminoantipyrine and dihydropyrimidone of vanillin. Int J Curr Pharm Res 2016;8:43-7.
8. Vasanth N, Melchias G, Kumaravel P. Biogenic silver nanoparticles mediated by Broussonetia papyrifera: anticancer and antimicrobial activity against pathogenic organisms. Asian J Pharm Clin Res 2017;10:93-8.
9. Deren W, Szewczyk Sadowska A, RuÅ‚ka J. The eradication of enzootic bovine leucosis in a large farm population. Polish J Veterinary Sci 2003;6:12-4.
10. Borovoy V. Problems of prevention and elimination of bovine leukemia in the territory of Russia. Veterinary Farm Animals 2015;1:30-7.
11. RuÅ‚ka J, Kubis P, BuzaÅ‚a E, KamiÅ„ski S, Deren W. The improvement of monitoring methods of cattle infection with bovine leukemia virus (BLV). Polish J Veterinary 2003;6:40-2.
12. Gutierrez G, RodrÃguez SM, Brogniez A, Gillet N, Golime R, Burny A. Vaccination against Î´âˆ’retroviruses: the bovine leukemia virus paradigm. Viruses 2014;6:2416-27.
13. Sperka T, Miklo G, Tie Y, Bagossi P, Zahuczky G, Boross P, et al. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases. J Gen Virol 2007;88:2052â€“63.
14. Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F, et al. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 2007;4:18.
15. Plotnikov E, Pehenko V, Plotnikov V. Antibacterial and immunomodulatory effects of hexamethylenetetramine (Methenamine) silver nitrate. Physiol Pharmacol 2016;19:247-52.